| 摘要 |
Disclosed is the use of a pharmaceutically effective amount of a compound of Formula (I) or a pharmaceutically acceptable salt or ester thereof, in the manufacture of a medicament for treating or preventing elevated Apo B, primary hypercholesterolemia, and/or primary dysbetalipoproteinemia, wherein R1 and R2 are independently chosen from a hydrogen atom or linear, branched, and/or cyclic C1-C6 alkyl groups, with the proviso that R1 and R2 are not both hydrogen. |
